My daughter, the second her eyes open, without a care for anyone sleeping or what time it might be, right when the rosy ...

Astellas Pharma has awarded its healthcare provider (HCP) and direct-to-consumer (DTC) business to CMI Media Group, Compas and WPP Media, the drugmaker confirmed Monday afternoon. According to ...

By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...

Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained about 2.5 times more plastic than nearby healthy prostate tissue.

Living with prostate cancer can be very stressful. It can affect a person’s body, life plans, relationships, and emotions. Many people don’t realize that people with prostate cancer are at risk for ...

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...